Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pressure Biosciences (OP: PBIO )

0.2342 +0.0042 (+1.83%)
Streaming Delayed Price Updated: 2:18 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pressure Biosciences

< Previous 1 2 3 4 5 6 7 8 Next >
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Partners with Skincare Leader, Icon and Pioneer
Via Investor Brand Network
Pressure BioSciences Secures Pivotal Cosmeceuticals Partnership for UST Platform with Dr. Denese SkinScience, 20-Year Leader with Over $0.5 Billion in QVC Sales
Collaborative UST-Driven Research and Development Agreement Announced with Dr. Adrienne Denese (QVC Icon, Skincare Visionary, Anti-Aging Pioneer, & Creator of Award-Winning SkinScience Labs) Targets... 
Via FinancialNewsMedia
Pressure BioSciences Secures Pivotal Cosmeceuticals Partnership for UST Platform With Dr. Denese SkinScience, 20-Year Leader With Over $0.5 Billion in QVC Sales
Via ACCESSWIRE
Pressure BioSciences, Inc. to Discuss Second Quarter 2022 Financial Results and Provide Business Update
Via ACCESSWIRE
Global Cosmeceuticals Market Size Projected Reach $96 Billion By 2029 as Demand is Booming
Palm Beach, FL – August 24, 2022 – FinancialNewsMedia.com News Commentary – The demand for cosmeceutical products is growing globally due to the rising prevalence of skin and hair disorders, increasing... 
Via FinancialNewsMedia
Exposures COVID-19
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Strategic Agreement with Canopy CBD Farms
Via Investor Brand Network
Pressure BioSciences Announces Contract for October 2022 Launch of Breakthrough Hemp-Derived CBD Product, Estimating $2 Million Incremental 2023 Revenue
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Approval to Manufacture Hemp-Derived CBD Products in South Easton Facility
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Announces Approval to Manufacture Hemp-Derived CBD Products in Massachusetts, Including Their Revolutionary CBD Nanoemulsions
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Gathers Leads at Events, Notes Rapid Market Expansion
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Doubles Growth Projections for UST Nanoemulsion Contracts Following Clear Confirmation of Unmet Needs in Exploding Cannabis Drinks Sector
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters New Contract Expected to Generate Significant 2023 Revenue, Drive Accelerated Future Growth
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform
PBI Partners with Leading Colorado Cannabis Company for Manufacture and Distribution of Novel Nano-CBD Topical Spray and Other Products, Anticipating $2 Million in 2023 Revenue Contribution 
From Pressure BioSciences Inc.
Via AccessWire
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Upcoming Emerging Growth Conference
Via Investor Brand Network
Pressure BioSciences to Expand on Upcoming Release of CBD Nanoemulsion Oral Spray at July 6th Emerging Growth Conference - Annual Revenue to PBI Expected to Exceed $1M
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Update/Q&A Session 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at 34th Emerging Growth Conference
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Participation in Upcoming Webinar Focused on Revolutionizing Development of Plant-Based Food Products
Via Investor Brand Network
Pressure BioSciences to Participate in FORCE Family Office June 30th Webinar: Revolutionizing the Development of Plant-Based Food Products
Investors, Analysts, and Advisors Invited to Attend this Real-Time, Interactive Presentation/Q&A Event 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters ‘Pivotal’ Agreement for Nanoemulsified CBD Spray for Oral Use
Via Investor Brand Network
Pressure BioSciences Announces Contracted Production Launch for Estimated $3,000,000 of UST-Processed, Nanoemulsified CBD Spray for Oral Use
Safer Medical of Montana, a Seasoned Distributor of Wellness Products with a Focus on Veterans, Partners with PBI as Exclusive Distributor for Highly Stable and Water-Soluble CBD Oral Aerosol Product 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Potential of UST(TM) as ‘Essential Tool in Future Beverage Development’
Via Investor Brand Network
Global Plant Based Protein Market Expected To Reach $40 Billion by 2027
Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – The pandemic has considerably transformed consumer buying patterns, with a steady shift being witnessed toward health-improving... 
Via FinancialNewsMedia
Pressure BioSciences’ Ultra Shear Technology™ Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market
Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI’s UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based Beverages South... 
Via FinancialNewsMedia
Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market
Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI's UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based Beverages 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses UST(TM) Platform, Early Access Program on Stock Day Podcast
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences Discusses Launch of Early Access Program for Ultra Shear Technology for the Processing of Nanoemulsions with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - June 1, 2022) - The Stock Day Podcast recently welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI"... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured in New ‘TechTalks’ Video
Via Investor Brand Network
Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences' CEO Richard T. Schumacher
SOUTH EASTON, MA / ACCESSWIRE / May 24, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that Emerging Technology Insider, a leading global source for business... 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases First-Quarter 2022 Financial Report, Corporate Update
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.